Logo-aim
Arch Iran Med. 2022;25(9): 600-608. doi: 10.34172/aim.2022.95
PMID: 37543885        PMCID: PMC10685772

Original Article

Targeted Next Generation Sequencing Revealed Novel Variants in the PKD1 and PKD2 Genes of Iranian Patients with Autosomal Dominant Polycystic Kidney Disease

Maryam Hosseinpour 1 ORCID, Fariba Ardalani 1 ORCID, Marzieh Mohseni 1 ORCID, Maryam Beheshtian 1 ORCID, Sanaz Arzhangi 1, Shahrzad Ossareh 2, Hossein Najmabadi 1 ORCID, Ali Nobakht 3, Kimia Kahrizi 1 * ORCID, Behrooz Broumand 4 * ORCID

Cited by CrossRef: 2

1- Liu Y, Xu K, Xiang Y, Ma B, Li H, Li Y, Shi Y, Li S, Bai Y. Role of MCP-1 as an inflammatory biomarker in nephropathy. Front Immunol. 2024;14 [Crossref]
2- Schott C, Lebedeva V, Taylor C, Abumelha S, Roshanov P, Connaughton D. Utility of Genetic Testing in Adults with Chronic Kidney Disease. CJASN. 2024; [Crossref]
3- Ciantar N, Zahra G, Delicata J, Sammut F, Calleja-Agius J, Farrugia E, Said E. Genotype-phenotype of autosomal dominant polycystic kidney disease in Malta. European Journal of Medical Genetics. 2024;69:104934 [Crossref]
4- Delrue C, Speeckaert M. Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine. JPM. 2024;14(12):1157 [Crossref]

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.